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In Brief
Epithelial morphogenesis is influenced by soluble signals from the surrounding mesenchyme, but the physical role of this tissue is unknown. Here, Kim, Pang et al. show that stereotyped differentiation of smooth muscle is required for branching morphogenesis of the airway epithelium in the mammalian lung.
INTRODUCTION
The developing lung begins as a simple epithelial tube surrounded by thick mesenchyme. New buds emerge sequentially along the length of the epithelial tube via domain branching, while the tip of the elongated tube bifurcates to form two daughter buds (Metzger et al., 2008) . Repetition of these bifurcations at defined angles (planar or orthogonal to the long axis of the parent tube) generates the stereotyped, hierarchically organized three-dimensional (3D) branched architecture of the lung (Metzger et al., 2008) . Pioneering tissue grafting studies revealed that the mesenchyme provides inductive cues for the branching epithelium (Alescio and Cassini, 1962; Grobstein, 1953) , and several signaling molecules have since been identified including fibroblast growth factor (FGF)-9, FGF10, bone morphogenetic protein (BMP)-4, and sonic hedgehog (SHH) (reviewed in Krasnow, 1999 and Morrisey and Hogan, 2010) . However, a possible connection between patterns of mesenchymal differentiation and airway epithelial branching has remained largely unexplored.
During morphogenesis of the lung, the mesenchyme differentiates into several cell types, including smooth muscle, vasculature, and nerves that envelop the entire airway epithelium as it branches (McCulley et al., 2015; Schachtner et al., 2000; Sparrow and Lamb, 2003; Tollet et al., 2001) . Among these, the airway smooth muscle forms tightly packed bundles around the circumference of the epithelium in a cranial to caudal direction along the primary bronchus (Sparrow and Lamb, 2003) . After the smooth muscle forms, it contracts spontaneously in a peristaltic wave, narrowing the airways and pushing luminal fluid toward the terminal ends (Featherstone et al., 2005; Jesudason et al., 2005; Schittny et al., 2000) . Although the presence of airway smooth muscle and its contractile behaviors have been observed in several species (Featherstone et al., 2005; Lewis, 1924; McCray, 1993; Schittny et al., 2000) , its role in patterning airway branching has not been defined Unbekandt et al., 2008) .
Here, we identified a role for stereotyped differentiation of airway smooth muscle in branching morphogenesis of the embryonic mouse lung and found that terminal bifurcations of the epithelium require the localized presence of smooth muscle at the cleft site. Time-lapse imaging of embryonic mouse lung explants revealed that changes in the shape of the epithelial bud coincide with patterned differentiation of smooth muscle. Remarkably, we found, using a transgenic reporter mouse, that a-smooth muscle actin (aSMA)-expressing cells appear adjacent to the airway epithelium prior to its bifurcation and then increase in density as they wrap around the bifurcating cleft and neck of the bud. Disrupting patterns of smooth muscle differentiation abolishes terminal bifurcation of the epithelium. Furthermore, surgically removing the smooth muscle from the cleft causes the epithelium to pop back into an un-bifurcated geometry. These results reveal a major role for the spatial pattern of smooth muscle differentiation during terminal bifurcation of the airway epithelium.
RESULTS

Terminal Bifurcation of the Airway Epithelium Is Accompanied by Smooth Muscle Differentiation
The branched architecture of the mammalian lung is sculpted in part by repeated bifurcations of the terminal ends of the growing airways (Metzger et al., 2008) . To follow the dynamics of tissue morphogenesis during terminal bifurcation, we imaged the branching of lungs explanted from E12 mouse embryos in real time ( Figure 1A ; Movie S1). At this stage of development, terminal bifurcations proceeded through a stereotyped sequence of events: the nascent epithelial bud first swelled at its tip (stage 1), it flattened (stage 2), and then a cleft appeared at the midline (stage 3; Figure 1B ). The cleft then deepened as each side of the bifurcation elongated (stage 4). Quantitative morphometric analysis ( Figure 1C ) revealed that the stem of the bud narrowed as the tip swelled ( Figure S1A ), and the neck of each side of the bifurcating bud narrowed as the cleft deepened (Figure S1B) , consistent with qualitative descriptions of bifurcation reported by others (Schnatwinkel and Niswander, 2013) .
The narrowing of the stem and neck regions of the bud during terminal bifurcation suggested that these changes in epithelial shape might be influenced by the surrounding mesenchyme. Both the airway smooth muscle and the vascular endothelium actively differentiate from mesenchymal progenitors during lung development (Kumar et al., 2014; Schachtner et al., 2000; Tollet et al., 2001 ). Immunostaining for aSMA or platelet endothelial cell adhesion molecule (PECAM) revealed that both cell (E and F) Smooth muscle differentiation is inhibited using nifedipine (10 mM). Shown are staining and qRT-PCR analysis of the smooth muscle markers aSMA (acta2), calponin-1, smooth muscle myosin heavy chain (smMHC), transgelin (tagln; SM22a), and the transcription factor SRF. Shown are mean ± SD for three independent experiments. Scale bar, 50 mm. (G) Branching morphogenesis was quantified as the number of terminal buds after drug treatment. Shown are mean ± SD for n R 9 for each condition; *p < 0.05; **p < 0.01. See also Figure S1 and Movies S1 and S2.
types were localized around the branching epithelium at E12.5 ( Figure S1C ). At areas actively undergoing bifurcation, the airway smooth muscle ( Figure 1D ; Movie S2) and the vascular endothelium ( Figure S1D ) appeared to wrap from the primary bronchus and up around the stem of the bud. To determine whether these mesenchymal cell populations are required for terminal bifurcation of the epithelium, we inhibited airway smooth muscle contraction using the L-type calcium channel blocker nifedipine (McCray, 1993; Roman, 1995) and blood vessel formation using the vascular endothelial growth factor receptor antagonist SU5416 (Fong et al., 1999) . Inhibiting smooth muscle contraction both reduced the extent of smooth muscle differentiation (Figures 1E and 1F) and blocked terminal bifurcation of the epithelium ( Figure 1G ; Figure S1F ). In contrast, although inhibiting vascular development significantly decreased the number of epithelial branches (Figures S1E and S1G), consistent with previously published work (Havrilak and Shannon, 2015; Lazarus et al., 2011) , the absence of vasculature did not completely prevent terminal bifurcation of the epithelium ( Figure 1G ).
Airway Smooth Muscle Localizes to the Cleft prior to Terminal Bifurcation
To investigate whether the pattern of airway smooth muscle plays an active role in epithelial bifurcation, we followed the dynamics of smooth muscle development using time-lapse imaging of embryonic lungs explanted from transgenic reporter mice that express red fluorescent protein (RFP) downstream of the aSMA promoter (aSMA-RFP) ( Figure S2A ) (Magness et al., 2004) . Analysis of the spatiotemporal dynamics of the epithelium and smooth muscle revealed that the localized RFP signal first appears at the midline of the basal surface of the swollen bud and then expands and increases in intensity at the bifurcating cleft and neck of the buds ( Figure 2A ; Movie S3). Thereafter, the intensity of the RFP signal continues to increase as the smooth muscle wraps around the entire neck of the bifurcating bud ( Figure 2B ). Strikingly, kymograph analysis of the area of the future cleft revealed that smooth muscle cells appear at the cleft site before the epithelial bifurcation begins (Figure 2A ). This appearance of the aSMA-RFP signal at the future cleft site was observed consistently in multiple explants 8.6 ± 1.9 hr prior to bifurcation of the epithelium ( Figure 2C ). Immunofluorescence analysis of fixed specimens confirmed the presence of a small population of aSMA-positive mesenchymal cells that appear at the midline of the basal surface of the epithelial bud prior to the formation of the cleft ( Figure 2D ; Figures S2B-S2D ). Based on these observations, we hypothesized that terminal bifurcation of the airway epithelium is directed by localized differentiation of smooth muscle cells ( Figure 2E ).
Stereotyped Smooth Muscle Differentiation Is Required for Terminal Bifurcation
To determine whether localized differentiation of smooth muscle at the future cleft site is required for terminal bifurcation of the airway epithelium, we pharmacologically perturbed the pattern of smooth muscle differentiation around the nascent buds. Disrupting FGF signaling using a fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor (SU5402) (Mohammadi et al., 1997) or activating SHH signaling using smoothened agonist (SAG) (Chen et al., 2002b; Radzikinas et al., 2011) induced the formation of ectopic smooth muscle around the entire airway epithelium but with different spatial patterns. Treatment with SU5402 caused smooth muscle to wrap completely around the airway epithelium, with smooth muscle cells aligning in a direction perpendicular to that of bud extension ( Figure 3A ; Figures S3A and S3B) but without increasing the overall expression of markers of smooth muscle differentiation ( Figure S3C ). Development of this tightly wrapped smooth muscle appeared to block further epithelial branching, even after initial formation of the cleft (Figures 3A-3C ; arrows in SU5402). In contrast, treatment with SAG led to randomly oriented ectopic smooth muscle throughout large regions of the mesenchyme, including the areas in between buds ( Figure 3A ; Figures S3A and S3B ). The epithelium failed to bifurcate and instead formed several shallow buckles along its surface ( Figure 3C ). Ectopic smooth muscle thus prevented terminal bifurcation and inhibited normal branching morphogenesis.
Conversely, treatment with either nifedipine or SHH antagonist cyclopamine (Chen et al., 2002a) decreased smooth muscle differentiation ( Figure S3C ), which was limited to regions around the primary bronchus and absent from regions surrounding the bud ( Figure 3A ; Figure S3A ). These treatments prevented terminal bifurcation of the epithelium ( Figure 3B ), and surprisingly led to the formation of shallow buckles along the surface of the buds ( Figure 3C ). The morphology of the buckled epithelium was distinct for each treatment despite the similar inhibition of smooth muscle differentiation ( Figure S3D) . Furthermore, the buckles that formed as a result of treatment with nifedipine were blocked by simultaneously inducing ectopic smooth muscle differentiation along the airway epithelium with SU5402 ( Figures 3A-3C) , suggesting that the presence of smooth muscle, not its contractility, shapes the epithelial bud during terminal bifurcation. Quantitative morphometric analysis of time-lapse movies of explants from aSMA-RFP embryos ( Figure 3D ; Movie S4) revealed that, as might be expected, drug treatments affected both the rate of smooth muscle differentiation and the rate of epithelial growth ( Figure 3E) . Inhibiting FGFR or activating SHH accelerated smooth muscle differentiation while simultaneously halting epithelial growth. Conversely, disrupting SHH halted smooth muscle differentiation while accelerating epithelial growth.
To directly modulate smooth muscle differentiation without altering signaling in the airway epithelium, we used an adenoviral approach to augment or reduce the levels of serum response factor (SRF) in the mesenchyme. Recombinant adenovirus only transduced the mesenchyme ( Figure S4A ), consistent with work by others showing that embryonic epithelium is refractory to adenovirus (Hsu et al., 2012) . Ectopic expression of SRF throughout the mesenchyme ( Figures S4B and S4C ) led to disorganized differentiation of smooth muscle cells ( Figure  4A ) and elevated levels of smooth muscle markers ( Figure 4B ). Conversely, short hairpin RNA (shRNA)-mediated depletion of SRF ( Figure S4B ) blocked smooth muscle differentiation around the growing epithelium (Figures 4A and 4B ; Figure S4D ). Both manipulations completely prevented terminal bifurcation ( Figure 4C ), with SRF depletion inducing epithelial buckling ( Figure 4D ). Consistently, surgically removing the mesenchyme from the epithelium at a stage immediately after cleft formation (stage 3) caused the epithelium to pop back into a flattened (stage 2) morphology ( Figure 4E ), suggesting that the initial cleft is sculpted physically by the mesenchyme. Localized differentiation of airway smooth muscle thus appears to be required for terminal bifurcation during branching morphogenesis of the epithelium in the embryonic mouse lung.
DISCUSSION
As the lung branches, a subpopulation of mesenchymal cells differentiate into smooth muscle that tightly surrounds the airway epithelium in a proximal to distal direction (Kumar et al., 2014) . Although its existence in the embryonic mammalian lung has been recognized for over a decade (Tollet et al., 2001) , the role of airway smooth muscle in epithelial branching has largely been ignored (Mitzner, 2004) . Similar patterns of smooth muscle development have been noted in other branching organs. In the neonatal prostate of the rat, the smooth muscle layer around the ducts is noticeably thicker proximally and thins distally (Hayward et al., 1996) . In the pubertal murine mammary gland, the myoepithelium surrounds the extending ducts, as well as the neck of the terminal end buds (Warburton et al., 1982) , and time-lapse analysis of mammary organoids revealed that myoepithelial cells frequently localize to sites of bifurcation (Ewald et al., 2008) . Whether these localized patterns of smooth muscle or myoepithelial cells direct epithelial bifurcation in the prostate or mammary gland remains to be determined, but our data show a clear role for localized smooth muscle differentiation in terminal bifurcation of the airway epithelium. Our time-lapse analysis revealed remarkable dynamics of aSMA-positive cells, which appear at the midline of epithelial buds prior to the formation of any noticeable clefts. Importantly, any perturbation in the stereotyped pattern of smooth muscle differentiation prevented terminal bifurcation of the epithelium. Because transgenic knockout of smooth muscle is embryonic lethal (Hines et al., 2013) , organ-specific genetic modulations will be required for definitive understanding of the role for visceral smooth muscle in epithelial morphogenesis.
Nonetheless, the spatiotemporal dynamics of airway smooth muscle cells suggest that they behave as a girdle around the bifurcating epithelial bud. As the airway epithelium grows, this girdle-like smooth muscle may constrain the epithelial tube at specific locations to direct the epithelial bifurcation. This conclusion is supported by our dissection experiments, which show that removing smooth muscle relaxes the epithelial cleft. The locations of smooth muscle around the bud neck and bifurcating cleft coincide with dense regions of extracellular matrix in the basement membrane of the lung (Liu et al., 2004; Mollard and Dziadek, 1998; Moore et al., 2005) . Moreover, the overlapping patterns of smooth muscle and matrix are similar to the patterns of fibronectin observed at cleft sites in the branching salivary gland, suggesting a potential role for smooth muscle in regulating epithelial cell-cell adhesions during terminal bifurcation (Larsen et al., 2006; Sakai et al., 2003) . In addition to these physical roles, the tightly packed smooth muscle could serve as a barrier to the diffusion of molecules between the epithelium and the mesenchyme, thus tuning bidirectional signaling, as in the induction of prostate morphogenesis (Thomson et al., 2002) . Regardless, in the absence of the smooth muscle landmark at the future cleft site, stereotyped branching is blocked and instead the growing epithelium buckles into the mesenchyme. This epithelial buckling could result from constrained epithelial growth (Varner et al., 2015) or from a reduction in intraluminal pressure, which is normally maintained by the aligned smooth muscle around the circumference of the epithelial tube (Featherstone et al., 2005; Jesudason et al., 2005) .
How airway smooth muscle differentiation is directed to the midline of the expanding epithelial bud is unclear. Several signaling molecules have been found to regulate the differentiation of smooth muscle adjacent to the proximal airway epithelium. FGF10-positive cells in the distal mesenchyme give rise to the smooth muscle cell population (Mailleux et al., 2005) , whereas FGF9 secreted by the mesothelium simultaneously inhibits differentiation of smooth muscle to restrict its localization to the proximal airway (Yi et al., 2009 ). In addition, SHH signaling from the airway epithelium induces smooth muscle differentiation within the neighboring mesenchyme (Weaver et al., 2003; White et al., 2006) . Whether and how these signals act as guidance cues for precisely patterned smooth muscle differentiation remains unclear. Further investigations are required to unlock the relationship between this physical mediator of airway branching and known genetic controls.
Airway epithelial branching morphogenesis is stereotyped in the mouse (Metzger et al., 2008) . Thousands of budding events are thought to follow three simple genetically encoded subroutines to build recursively the complex branching structure of the lung, yet how the budding process is restricted to specific times and locations remains a mystery. The close spatiotemporal coincidence of smooth muscle differentiation and epithelial bifurcation suggests a physical or signaling role for stereotyped differentiation of the mesenchyme in the shaping of the airway epithelium. It will be interesting to determine whether stereotyped smooth muscle differentiation is controlled by the same genetically encoded subroutines as epithelial branching morphogenesis. Given the prevalence of smooth muscle around branching epithelial tissues, spatiotemporally patterned smooth muscle differentiation may represent a general physical strategy to sculpt complex epithelial architectures.
EXPERIMENTAL PROCEDURES Mice
Timed-pregnant CD1 mice were obtained from Charles River. Breeding of aSMA-RFP transgenic reporter mice (Magness et al., 2004) and isolation of embryos were carried out in accordance with institutional guidelines following the NIH Guide for the Care and Use of Laboratory Animals and approved by the Mayo Clinic's Institutional Animal Care and Use Committee.
Organ Culture
Ex vivo culture of embryonic lungs was performed following previously described protocols (Carraro et al., 2010) . Briefly, lungs from E12 mouse embryos were dissected in PBS supplemented with antibiotics (50 units/ml of penicillin and streptomycin; Invitrogen) and cultured on porous membranes (nucleopore polycarbonate track-etch membrane, 8 mm pore size, 25 mm diameter; Whatman) in DMEM/F12 medium (without HEPES) supplemented with 5% fetal bovine serum (FBS, heat inactivated; Atlanta Biologicals) and antibiotics (50 units/ml of penicillin and streptomycin). Reagents used to perturb the pattern of smooth muscle and vascular endothelial differentiation included cyclopamine (1 or 2 mM; Tocris), nifedipine (10 mM; Sigma), SU5402 (5 or 10 mM; Santa Cruz), SU5416 (50 mM; Cayman Chemical), and SAG (1 or 2 mg/ml; Calbiochem). To disrupt smooth muscle differentiation specifically, lung explants were transduced with custom recombinant adenoviruses (Vector Biolabs)-adenovirus encoding GFP and SRF (AdSRF), GFP and shRNA against SRF (AdshSRF), or GFP alone (AdGFP)-for 48 hr. To surgically remove the mesenchyme, explants were incubated in 10 units/ml of dispase (Invitrogen) on ice for 15 min. The reaction was quenched by submerging the explants in FBS for 10 min. The explants were then transferred to a dissection dish containing PBS, and the mesenchyme was removed manually using fine tungsten needles .
Immunofluorescence Staining and Imaging
Lung explants were fixed with 4% paraformaldehyde in PBS for 15 min at room temperature followed by washing with 0.3% Triton X-100 in PBS and blocking with 10% goat serum. Samples were incubated with primary antibodies against E-cadherin (Invitrogen), aSMA (Sigma), or PECAM (rat anti-mouse CD31; BD Biosciences), followed by Alexa Fluor-conjugated secondary antibodies and nuclear counter-staining with Hoechst 33342 (Invitrogen). Stained lungs were dehydrated and cleared with Murray's clear (1:2 ratio of benzyl alcohol to benzyl benzoate; Sigma) and confocal images were collected using a spinning disk confocal (Bio-Rad) fitted to an inverted microscope. For live imaging, explants were cultured over porous membranes within custom-made glass bottom culture dishes within a stage-top incubator (Pathology Devices). The morphology of the explants was monitored every 24 hr under bright field on an inverted microscope (Nikon Ti).
Image Analysis and Statistics
Quantitative image analysis and image projections were completed using ImageJ (Schneider et al., 2012) . The orientation of smooth muscle cells in the neck and bud regions of at least three different lungs for each treatment were calculated using the OrientationJ plugin (Rezakhaniha et al., 2012) . To quantify differences in branching, the fold-change in the number of terminal buds was determined by counting the terminal buds at the end of the experiment and normalizing to the number at time zero for each explant. To characterize effects on terminal bifurcation per se, the total number of clefts (or buckles) for each bud was counted at the end of the culture period. ANOVA was conducted using IBM SPSS Statistics 19 for comparisons among different treatments.
qRT-PCR Analysis
Total RNA from cultured lung explants was isolated using the QIAGEN RNeasy fibrous tissue mini kit and reverse-transcribed using the Verso cDNA synthesis kit (Thermo Scientific) according to manufacturer's instructions. qRT-PCR was performed using the Bio-Rad Mini Opticon instrument and iTaq Universal SYBR Green Supermix (Bio-Rad). Amplification was followed by melting curve analysis to verify the presence of a single PCR product. The expression level of each mRNA was normalized to that of 18S in the same sample. Primer sequences are listed in Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures, four figures, and four movies and can be found with this article online at http://dx.doi.org/10.1016/j.devcel.2015.08.012. 
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